Title:
COMPOUNDS USEFUL AS RET INHIBITORS
Document Type and Number:
Japanese Patent JP2023103326
Kind Code:
A
Abstract:
To provide: prescribed compounds that function as inhibitors of RET (rearranged during transfection) kinase enzyme activity; processes for preparation of the compounds; pharmaceutical compositions comprising the compounds; and methods for treatment of proliferative disorders, such as cancer, and other diseases or conditions in which RET kinase activity is implicated.SOLUTION: The present invention provides compounds represented by formula I.SELECTED DRAWING: None
Inventors:
ALLAN JORDAN
REBECCA NEWTON
GEORGE HYND
JONATHAN MARK SUTTON
BOHDAN WASZKOWYCZ
REBECCA NEWTON
GEORGE HYND
JONATHAN MARK SUTTON
BOHDAN WASZKOWYCZ
Application Number:
JP2023076767A
Publication Date:
July 26, 2023
Filing Date:
May 08, 2023
Export Citation:
Assignee:
CANCER RESEARCH TECH LTD
International Classes:
C07D487/04; A61K31/519; A61P35/00
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mihiro
Tatsuhiko Abe
Shinya Mihiro
Tatsuhiko Abe